SCHEMBL717707

SCHEMBL717707

CC(C)C=CC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4114676 1.00
SCHEMBL16654271 0.86
SCHEMBL2486910 0.82 GABRP (0.40)
SCHEMBL14307543 0.80
SCHEMBL14520488 0.80
SCHEMBL20197695 0.80
SCHEMBL2354840 0.80
SCHEMBL2354839 0.80
SCHEMBL10929917 0.78
SCHEMBL8772984 0.78 GABRP (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12270810-B2 QMAX assay and applications (II) ESSENLIX CORPORATION (US) 2025-04-08 US claimed
US-20240325593-A1 OCCLUSIVE IMPLANT COMPOSITIONS UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2024-10-03 US claimed
EP-4400166-A2 METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS Contraline, Inc. (US) 2024-07-17 EP claimed
EP-3565484-B1 COMPOSITIONS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS CONTRALINE INC (US) 2024-04-03 EP claimed
US-11904068-B2 Occlusive implant compositions UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2024-02-20 US claimed
CN-116239603-A 2-aminopyrimidine heterocyclic compound and application thereof 江西科技师范大学 2023-06-09 CN claimed
CN-116102997-A Preparation method of touch instant conductive adhesive 苏州世华新材料科技股份有限公司 2023-05-12 CN claimed
CN-111732597-B Preparation and application of 2-aminopyrimidine heterocyclic compound containing 4-amidophenoxy 江西科技师范大学 2022-11-01 CN claimed
CN-114981072-A Wettable silicone hydrogel contact lenses 爱尔康公司 2022-08-30 CN claimed
US-20220168461-A1 OCCLUSIVE IMPLANT COMPOSITIONS UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2022-06-02 US claimed
WO-2002089679-A9 HYDROGEL VASO-OCCLUSIVE DEVICE CONCENTRIC MEDICAL (US) 2003-04-10 WO claimed
US-20030004568-A1 Coated combination vaso-occlusive device CONCENTRIC MEDICAL 2003-01-02 US claimed
US-20020193812-A1 Hydrogel vaso-occlusive device CONCENTRIC MEDICAL 2002-12-19 US claimed
WO-2002089679-A1 HYDROGEL VASO-OCCLUSIVE DEVICE CONCENTRIC MEDICAL (US) 2002-11-14 WO claimed
WO-2002089863-A1 BIOACTIVE POLYMER VASO-OCCLUSIVE DEVICE CONCENTRIC MEDICAL (US) 2002-11-14 WO claimed
WO-2002089865-A2 COATED COMBINATION VASO-OCCLUSIVE DEVICE CONCENTRIC MEDICAL (US) 2002-11-14 WO claimed
EP-1046037-A1 IMPROVED MAGNETIC PARTICLES, METHOD FOR OBTAINING SAME AND USES FOR SEPARATING MOLECULES BIO MERIEUX (FR) 2000-10-25 EP claimed
US-6103865-A COUPLING SULFUR COMPOUND WITH HYDROPHILIC GROUPS OF POLYMER TO AFFECT PH DEPENDENT POLYMER SWELLING/SOLUBILITY KWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2000-08-15 US claimed
US-5952126-A COPOLYMER OF A (METH)ACRYLAMIDE MONOMER AND A CROSSLINKING AGENT COMPRISING A DI(METH)ACRYLATE ENDCAPPED ETHYLENE GLYCOL HAVING 3-30 REPEATING ETHYLENE OXIDE UNITS; NONLEAKING, EXCELLENT CONDUCTIVITY, EASILY PROCESSED SAMSUNG ELECTRONICS CO., LTD. (KR) 1999-09-14 US claimed
WO-1999035500-A1 IMPROVED MAGNETIC PARTICLES, METHOD FOR OBTAINING SAME AND USES FOR SEPARATING MOLECULES BIO MERIEUX (FR) 1999-07-15 WO claimed